Recent research has suggested a potential link between statins, including rosuvastatin, and cancer prevention or treatment. Statins have been observed to have pleiotropic effects, which include anti-inflammatory and immunomodulatory properties. These effects could theoretically contribute to cancer prevention by inhibiting cell proliferation, inducing apoptosis, and reducing inflammation and oxidative stress within the body.
